Acadia pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Acadia pharmaceuticals Contact Number

Contact Us Acadia Pharmaceuticals

7 hours ago Acadia-pharm.com Show details

(858) 558-2871

Contact Us Acadia Pharmaceuticals Inc. Corporate Headquarters 12830 El Camino Real, Suite 400 San Diego, CA 92130 Tel: +1 (858) 558-2871 Fax: +1 (858) 212-0513. R&D Center

1. 502 Carnegie Ctr Ste 300, Princeton, NJ 08540 · (858) 558-2871DIRECTIONSWEBSITE

Category: Contact SupportShow more

Contact us at Acadia Pharmaceuticals Inc. NUPLAZID

5 hours ago Nuplazid.com Show details

(844) 422-2342

CONTACT US. Acadia Pharmaceuticals Inc. 12830 El Camino Real, Suite 400. San Diego, CA 92130. (844) 4ACADIA. (844) 422-2342. You can always call a Care Coordinator at Acadia Connect for guidance on insurance coverage, financial resources, and prescription support. Call (844) 737-2223.

Category: Contact SupportShow more

Acadia Pharmaceuticals Inc. Company Contact Information

6 hours ago Adapt.io Show details

Get Acadia Pharmaceuticals Inc. company's verified contact number +1*****871, web address, revenue, total contacts 330, industry Healthcare, Pharmaceuticals, & Biotech and location at Adapt.io

Category: Contact SupportShow more

Acadia Pharmaceuticals

9 hours ago Acadia-pharm.com Show details

Acadia is trailblazing breakthroughs in neuroscience to elevate life. We are at the forefront of healthcare, fighting for breakthroughs in our science, our therapies and the way we work, but also in the lives of the people we serve. At Acadia, we are committed to our purpose: we …

Category: Contact NumberShow more

ACADIA Pharmaceuticals Inc. Operations Contacts Business

6 hours ago Adapt.io Show details

Find the ACADIA Pharmaceuticals Inc. company's Operations team/department contact details such as business emails, phone numbers, web address and other …

Category: Contact SupportShow more

Acadia Pharmaceuticals Inc. Crunchbase Company Profile

2 hours ago Crunchbase.com Show details

(858) 558-2871

Contact Email [email protected]acadia-pharm.com. Phone Number (858) 558-2871. Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo

Category: Contact NumberShow more

Acadia Pharmaceuticals Inc. Company Profile San Diego

Just Now Dnb.com Show details

(858) 558-2871

ACADIA Pharmaceuticals develops small molecule drugs for the treatment of central nervous system disorders. The biopharmaceutical company's pimavanserin (Nuplazid) was approved by the FDA in 2016 as a treatment for Parkinson's disease psychosis, a common development with the disease. Two other clinical-stage candidates are being developed in collaboration with Allergan to treat patients with

Employees: 601
Phone: (858) 558-2871
Location: 12830 El Camino Real Ste 400, San Diego, 92130-2976

Category: Contact NumberShow more

ACADIA PHARMACEUTICALS INC. BestCompanyTexas.com

Just Now Bestcompanytexas.com Show details

Texas Taxpayer Number assigned to ACADIA PHARMACEUTICALS INC. is 32055659489. Texas SOS File Number of this company is 0802098486. This company state of formation is DE. ACADIA PHARMACEUTICALS INC. mailing address is 3611 VALLEY CENTRE DR …

Category: Contact NumberShow more

ACADIA Pharmaceuticals Company Profile Office Locations

9 hours ago Craft.co Show details

ACADIA Pharmaceuticals has 601 employees across 2 locations and $441.76 M in annual revenue in FY 2020. See insights on ACADIA Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

ACADIA Pharmaceuticals Inc. Email Format acadiapharm

9 hours ago Rocketreach.co Show details

ACADIA Pharmaceuticals Inc. uses 5 email formats, with first_initial last (ex. [email protected]acadia-pharm.com) being used 92.8% of the time. Get Verified Emails for ACADIA Pharmaceuticals Inc. Employees. ACADIA Pharmaceuticals Inc.'s Email Format. Percentage. first_initial last.

Category: Contact NumberShow more

Acadia Connect Treatment Form

5 hours ago Nuplazidhcp.com Show details

Primary contact name *Phone number *Fax Prescriber Authorization: I attest that I have obtained written permission, (“PHI”) to Acadia Pharmaceuticals Inc. or its representatives or agents (collectively “Acadia”) as may be necessary for the patient’s participation in a program designed

Category: Contact NumberShow more

Contact Us Acadia Healthcare

7 hours ago Acadiahealthcare.com Show details

615-861-6000

Acadia Corporate Headquarters 6100 Tower Circle, Suite 1000 Franklin, TN 37067. Tel: 615-861-6000 Toll Free: 855-526-8228 Fax: 615-261-9685

Category: Contact SupportShow more

Acadia Pharmaceuticals Reports Third Quarter 2020

2 hours ago Ir.acadia-pharm.com Show details

(858) 914-7161

Media Contact: Acadia Pharmaceuticals Inc. Eric Endicott (858) 914-7161 [email protected]acadia-pharm.com Investor Contact: Acadia Pharmaceuticals Inc. Mark Johnson, CFA (858) 261-2771 [email protected]acadia-pharm.com. Source: Acadia Pharmaceuticals Inc.

Category: Contact NumberShow more

ACADIA Pharmaceuticals Inc. (ACAD) Company Profile

6 hours ago Stockanalysis.com Show details

Company profile for ACADIA Pharmaceuticals Inc. (ACAD) with a description, list of executives, contact details and other key facts. Company profile for ACADIA Pharmaceuticals Inc. (ACAD) with a description, list of executives, contact details and other key facts. CUSIP Number: 004225108: ISIN Number: US0042251084: Employer ID: 06-1376651

Category: Contact NumberShow more

Acadia Pharmaceuticals A/S Company Profile København K

Just Now Dnb.com Show details

Acadia Pharmaceuticals A/S is located in København K, Hovedstaden, Denmark and is part of the Scientific Research and Development Services Industry. Acadia Pharmaceuticals A/S has 2 total employees across all of its locations and generates $140,932 in sales (USD). (Employees and Sales figures are modelled).

Employees: 2
Phone: 30505698
Location: Nørregade 21C/O Bruun & Hjejle, København K, 1165

Category: Contact NumberShow more

Contact ACADIA

3 hours ago Acadia.org Show details

Institutional members can contact [email protected]acadia.org directly to request a job posting. Please include the job posting text, relevant link to job posting, and an image formatted 432 x 275 pixels. Non-members. Non-members can post a job opening at cost USD$150.00 per posting. Payment is to be submitted via Paypal.

Category: Contact SupportShow more

Acadia Pharmaceuticals Inc. AL, CA, CO, DE, FL, GA, MA

Just Now Bizapedia.com Show details

ACADIA PHARMACEUTICALS INC. ALABAMA FOREIGN CORPORATION: WRITE REVIEW: Address: 3611 Valley Centre Drive Ste 300 San Diego, CA 92130: Registered Agent: Corporation Service Company Inc: Filing Date: November 13, 2014: File Number: 321-912: Contact Us About The Company Profile For Acadia Pharmaceuticals Inc.

Category: Contact NumberShow more

News Releases Acadia Pharmaceuticals Inc.

1 hours ago Ir.acadia-pharm.com Show details

Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results. 07/21/21. The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis. 07/21/21. Acadia Pharmaceuticals to Announce Second Quarter 2021 Financial Results on August 4, 2021.

Category: Contact NumberShow more

About Us Acadia Healthcare

9 hours ago Acadiahealthcare.com Show details

Acadia is a leading provider of behavioral healthcare services across the United States. As of June 30, 2021, Acadia operated a network of 229 behavioral healthcare facilities with approximately 10,100 beds in 40 states and Puerto Rico. With more than 20,000 employees serving approximately 70,000 patients daily, Acadia is the largest stand

Category: Contact NumberShow more

ACADIA Pharmaceuticals Biocom California

3 hours ago Biocom.org Show details

Contact us here: [email protected] About ACADIA Pharmaceuticals . Biotech Company ACADIA Pharmaceuticals (Nasdaq: ACAD) is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is focused on developing a portfolio consisting of

Category: Contact NumberShow more

Official Title: A multicenter, openlabel extension study

6 hours ago Clinicaltrials.gov Show details

Protocol Number: ACP-103-015 . A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP -103 in the Treatment of Psychosis in Parkinson’s Disease. ACADIA Pharmaceuticals Inc. Version 1: 18 December 2013 . Version 2: 05 August 2014 . CONFIDENTIAL (

Category: Contact NumberShow more

Acadia Pharmaceuticals: This Is Not a Pharmaceutical

5 hours ago Ffj-online.org Show details

Given the fact that Acadia hired a significant number of former Avanir sales staffers, a substantial number of doctors have ended up receiving consulting payments from both Avanir and Acadia in the same calendar year: A total of 31 did in 2017, as did 29 in 2016.

Category: Contact NumberShow more

Acura Pharmaceuticals, Inc LinkedIn

8 hours ago Linkedin.com Show details

Acadia Pharmaceuticals Inc. Pharmaceuticals San Diego, California • Limitx™ Technology is designed to retard the release of active drug ingredients when an excess number of tablets are

Category: Contact NumberShow more

Acadia Pharmaceuticals Inc. Funding, Financials

1 hours ago Crunchbase.com Show details

Acadia Pharmaceuticals Inc. has raised a total of $811.7M in funding over 14 rounds. Their latest funding was raised on Sep 20, 2019 from a Post-IPO Equity round. Acadia Pharmaceuticals Inc. is registered under the ticker NASDAQ:ACAD . Their stock opened with $7.00 in its May 27, 2004 IPO. Acadia Pharmaceuticals Inc. is funded by 17 investors.

Category: Contact NumberShow more

Mona Darwish Senior Dire.. ACADIA Pharmaceuticals

Just Now Zoominfo.com Show details

View Mona Darwish's business profile as Senior Director, Clinical Pharmacology at ACADIA Pharmaceuticals. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

ACADIA Pharmaceuticals Number of Employees 20062021

9 hours ago Macrotrends.net Show details

ACADIA Pharmaceuticals number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of

Category: Contact NumberShow more

Acadia Pharmaceuticals to Present New Scientific Data on

5 hours ago Apnews.com Show details

(818) 395-3043

CONTACT: Acadia Pharmaceuticals Inc. Deb Kazenelson (818) 395-3043. [email protected]acadia-pharm.com. Investor Contact: Acadia Pharmaceuticals Inc. Mark Johnson, CFA (858) 261-2771. [email protected]acadia-pharm.com. KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA COLORADO INDUSTRY KEYWORD: MEDICAL SUPPLIES HEALTH HOSPITALS GENERAL HEALTH PHARMACEUTICAL

Category: Contact NumberShow more

ACADIA PHARMACEUTICALS INC. : ACAD Stock Price

4 hours ago Marketscreener.com Show details

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders. The Company's product pipeline includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319.

Category: Contact NumberShow more

HAGENS BERMAN Encourages Acadia Pharmaceuticals (ACAD

6 hours ago Ca.finance.yahoo.com Show details

844-916-0895

Contact An Attorney Now: [email protected] 844-916-0895. Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) Securities Fraud Action: The complaint alleges that Defendants misrepresented facts concerning Acadia's supplemental new drug application ("sNDA") for NUPLAZID® (pimavanserin), which treats dementia-related psychosis ("DRP").

Category: Contact NumberShow more

ACAD Company Profile for ACADIA PHARMACEUTICALS INC

1 hours ago Msn.com Show details

ACADIA Pharmaceuticals Inc. (ACADIA) is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines to address the medical needs in central nervous

Category: Contact NumberShow more

Will ACADIA Pharmaceuticals Inc. (ACAD) Underperform the

9 hours ago Investorsobserver.com Show details

ACADIA Pharmaceuticals Inc. (ACAD) stock has fallen -1.17% while the S&P 500 is up 0.18% as of 11:45 AM on Monday, Oct 18. ACAD is down -$0.20 from the previous closing price of $17.51 on volume of 430,473 shares.

Category: Contact NumberShow more

Acadia Pharmaceuticals American Consequences

6 hours ago Americanconsequences.com Show details

Given the fact that Acadia hired a significant number of former Avanir sales staffers, a substantial number of doctors have ended up receiving consulting payments from both Avanir and Acadia in the same calendar year: A total of 31 did in 2017, as did 29 in 2016.

Category: Contact NumberShow more

Did Hedge Funds Make The Right Call On ACADIA

3 hours ago Finance.yahoo.com Show details

Hedge fund activity in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) At Q1's end, a total of 28 of the hedge funds tracked by Insider Monkey were long this stock, a change of …

Category: Contact NumberShow more

EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Acadia

5 hours ago Marketscreener.com Show details

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021, inclusive (the “Class Period”).A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June

Category: Contact NumberShow more

ACADIA Pharmaceuticals to Present New Clinical Data and

7 hours ago Businesswire.com Show details

(858) 768-6068

Media Contact: ACADIA Pharmaceuticals Inc. Maurissa Messier (858) 768-6068 [email protected]acadia-pharm.com Contacts Investor Contact: ACADIA Pharmaceuticals Inc. Mark Johnson, CFA (858) 261-2771 [email protected]acadia

Category: Contact NumberShow more

What Will ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Be

3 hours ago Stocksregister.com Show details

According to the data, the short interest in ACADIA Pharmaceuticals Inc. (ACAD) stood at 3.73% of shares outstanding as of Jun 14, 2021; the number of short shares registered in May 13, 2021 reached 7.25 million. The stock has fallen by -66.63% since the beginning of the year, thereby showing the potential of a further growth.

Category: Contact NumberShow more

Acadia Pharmaceuticals Reports Third Quarter 2020

9 hours ago Bloomberg.com Show details

Acadia Pharmaceuticals Reports Third Quarter 2020 Financial Results - 3Q20 Net Sales of $120.6 Million, a 27% Increase Over 3Q19 Business Wire SAN DIEGO -- November 4, 2020 Acadia Pharmaceuticals

Category: Contact NumberShow more

ACAD 10DAY DEADLINE ALERT: Hagens Berman Encourages

2 hours ago Finance.yahoo.com Show details

San Francisco, California--(Newsfile Corp. - June 8, 2021) - Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with …

1. Author: Newsfile Corp.

Category: Contact NumberShow more

Acadia Pharmaceuticals Inc. LinkedIn

4 hours ago Uk.linkedin.com Show details

Acadia Pharmaceuticals Inc. 33,990 followers on LinkedIn. Acadia is trailblazing breakthroughs in neuroscience to elevate life. Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most.

Category: Contact NumberShow more

Glancy Prongay & Murray LLP Reminds Investors of Looming

3 hours ago Apnews.com Show details

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 18, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Acadia Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD) securities between June 15, 2020 and April 4, 2021, inclusive (the “Class Period”).

Category: Contact NumberShow more

What’s so great about ACADIA Pharmaceuticals Inc. (ACAD

6 hours ago Bovnews.com Show details

Currently, 0.20 percent of ACADIA Pharmaceuticals Inc. shares are owned by insiders, and 94.20 percent are held by financial institutions. Ridloff Elena, the EVP and CFO at ACADIA Pharmaceuticals Inc. (ACAD) has sold 1,032 shares of firm on Apr 30 at a price of $20.33 against the total amount of $20981.0.

Category: Contact NumberShow more

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages …

7 hours ago Nz.finance.yahoo.com Show details

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm, June 18th Deadline Approaching in Securities Fraud Lawsuit

Category: Contact NumberShow more

ACAD Stock Forecast, Price & News (ACADIA Pharmaceuticals)

6 hours ago Marketbeat.com Show details

(858) 558-2871

How can I contact ACADIA Pharmaceuticals? ACADIA Pharmaceuticals' mailing address is 3611 VALLEY CENTRE DRIVE SUITE 300, SAN DIEGO CA, 92130 . The biopharmaceutical company can be reached via phone at (858) 558-2871 or via email at [email protected] .

Category: Contact NumberShow more

Bragar Eagel & Squire, P.C. Reminds Investors That Class

2 hours ago Au.finance.yahoo.com Show details

Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) Class Period: June 15, 2020 to April 4, 2021. Lead Plaintiff Deadline: June 18, 2021. Acadia is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.

Category: Contact NumberShow more

Rebecca Chow at Acadia Pharmaceuticals Inc. AroundDeal

9 hours ago Arounddeal.com Show details

Acadia strongly recommends individuals, who receive email solicitations, to carefully verify the authenticity of the correspondence before responding. Never provide personal information or click on links if you are unsure a communication’s legitimacy. If in doubt, please contact [email protected]acadia-pharm.com to verify.

Category: Contact NumberShow more

Is ACADIA Pharmaceuticals Inc. (ACAD) a Loser in the

9 hours ago Investorsobserver.com Show details

ACADIA Pharmaceuticals Inc. (ACAD) stock is trading at $16.81 as of 12:56 PM on Thursday, Sep 30, a drop of -$0.15, or -0.88% from the previous closing price of $16.96. The stock has traded between $16.54 and $17.18 so far today. Volume today is less active than usual.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is acadia pharmaceuticals corporation?

ACADIA Pharmaceuticals (formerly known as Receptor Technologies) is a biopharmaceutical company focused on the development and commercialization of medicines that address medical needs in central nervous system (CNS) disorders.

What do you need to know about acadia healthcare?

Acadia Healthcare’s mission is to create a world-class organization that sets the standard of excellence in the treatment of specialty behavioral health and addiction disorders. Acadia’s management style and philosophy is one of collaboration and flexibility as we create an energetic and team oriented service delivery system.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Amgen
Att
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes